mRNA vaccine technology is the next frontier for combatting cancer and autoimmune disease, says mRNA expert Jeff Coller.

As federal policy moves away from research on mRNA vaccines, Jeff Coller, Ph.D., Bloomberg Distinguished Professor of RNA Biology and Therapeutics at The Johns Hopkins University and professor of molecular biology and genetics at the Johns Hopkins University School of Medicine, examines this issue and points out why such a policy is a mistake for the public’s health.

In radio spots broadcast nationally on CBS Radio and many other domestic and international outlets, Coller sets the record straight on mRNA and explains how it could excite the immune system to attack cancer tumors. Listen to the podcast series.